The observed associations between missed basal insulin doses and reduced glycemic control highlight a need for tools, such as smart insulin pens and other technologies, that provide precise injection data and empower patients and health care practitioners (HCPs) to improve the treatment of diabetes.13,15. Here, INS is linked to diabetes mellitus.